New antiplatelet drug Kengreal approved by US FDA

New antiplatelet drug Kengreal approved by US FDA

FDA approves new antiplatelet drug used during heart procedure – The U.S. Food and Drug Administration approved Kengreal (cangrelor), an intravenous antiplatelet drug that prevents formation of harmful blood clots in the coronary arteries, the blood vessels that supply blood to the heart.

Middle aged active have low risk of sudden cardiac arrest

Middle aged active have low risk of sudden cardiac arrest

Middle-aged athletes at low risk for sudden cardiac arrest while exercising — Physically active middle-aged adults have low risk of sudden cardiac arrest – Sudden cardiac arrest during sports activities is relatively low among physically active middle-aged adults, and older people can exercise without worrying about triggering a heart rhythm disturbance, revealed by American researchers.

Four eggs per week lowers type 2 diabetes risk

Four eggs per week lowers type 2 diabetes risk

Eating eggs reduces risk of type 2 diabetes — Four eggs per week lowers type 2 diabetes risk – Four eggs per week lowers type 2 diabetes risk revealed by researchers from University of Eastern Finland in a new study published in American Journal of Clinical Nutrition, highlighting the benefit of egg consumption in controlling type 2 diabetes.

Lower systolic blood pressure reduces stroke risk

Lower systolic blood pressure reduces risk of stroke – Older people with systolic blood pressure lower than 140 millimeters of mercury (mm Hg) have a lower risk of stroke, revealed in a study study presented at the American Stroke Association’s International Stroke Conference 2015.

Cigarette smoking may cause more deaths than currently estimated

Cigarette smoking is even more deadly than you think — US Smoking deaths may be underestimated: Study – A new study suggests that current estimates significantly underestimate the number of Americans who die from cigarette smoking. The Surgeon General estimates that each year, smoking kills about 480,000 Americans.

New cholesterol drug alirocumab halved number of heart attacks and strokes

New drug alirocumab halved number of heart attacks and strokes – An experimental cholesterol-lowering drug from Sanofi and Regeneron Pharmaceuticals roughly halved the number of heart attacks and strokes in a clinical trial, revealed by researchers at the European Society of Cardiology yearly gathering in Barcelona.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia